vs

Side-by-side financial comparison of SHOE CARNIVAL INC (SCVL) and Vertex, Inc. (VERX). Click either name above to swap in a different company.

SHOE CARNIVAL INC is the larger business by last-quarter revenue ($297.2M vs $194.7M, roughly 1.5× Vertex, Inc.). SHOE CARNIVAL INC runs the higher net margin — 4.9% vs -3.6%, a 8.5% gap on every dollar of revenue. On growth, Vertex, Inc. posted the faster year-over-year revenue change (9.1% vs -3.2%). Over the past eight quarters, Vertex, Inc.'s revenue compounded faster (11.4% CAGR vs 3.0%).

Shoe Carnival Inc. is an American retailer of family footwear. The company operates 429 stores throughout the midwest, south, and southeast regions, and Puerto Rico. It was founded by David Russell in 1978 and is headquartered in Fort Mill, South Carolina as of 2025.

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

SCVL vs VERX — Head-to-Head

Bigger by revenue
SCVL
SCVL
1.5× larger
SCVL
$297.2M
$194.7M
VERX
Growing faster (revenue YoY)
VERX
VERX
+12.3% gap
VERX
9.1%
-3.2%
SCVL
Higher net margin
SCVL
SCVL
8.5% more per $
SCVL
4.9%
-3.6%
VERX
Faster 2-yr revenue CAGR
VERX
VERX
Annualised
VERX
11.4%
3.0%
SCVL

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
SCVL
SCVL
VERX
VERX
Revenue
$297.2M
$194.7M
Net Profit
$14.6M
$-7.0M
Gross Margin
37.6%
64.8%
Operating Margin
6.3%
-1.3%
Net Margin
4.9%
-3.6%
Revenue YoY
-3.2%
9.1%
Net Profit YoY
-23.9%
89.7%
EPS (diluted)
$0.53

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SCVL
SCVL
VERX
VERX
Q4 25
$297.2M
$194.7M
Q3 25
$306.4M
$192.1M
Q2 25
$277.7M
$184.6M
Q1 25
$262.9M
$177.1M
Q4 24
$306.9M
$178.5M
Q3 24
$332.7M
$170.4M
Q2 24
$300.4M
$161.1M
Q1 24
$280.2M
$156.8M
Net Profit
SCVL
SCVL
VERX
VERX
Q4 25
$14.6M
$-7.0M
Q3 25
$19.2M
$4.0M
Q2 25
$9.3M
$-961.0K
Q1 25
$14.7M
$11.1M
Q4 24
$19.2M
$-67.8M
Q3 24
$22.6M
$7.2M
Q2 24
$17.3M
$5.2M
Q1 24
$15.5M
$2.7M
Gross Margin
SCVL
SCVL
VERX
VERX
Q4 25
37.6%
64.8%
Q3 25
38.8%
63.1%
Q2 25
34.5%
65.7%
Q1 25
34.9%
63.8%
Q4 24
36.0%
65.6%
Q3 24
36.1%
64.8%
Q2 24
35.6%
63.7%
Q1 24
35.6%
61.1%
Operating Margin
SCVL
SCVL
VERX
VERX
Q4 25
6.3%
-1.3%
Q3 25
8.2%
2.2%
Q2 25
4.3%
-2.1%
Q1 25
5.3%
2.5%
Q4 24
8.0%
-7.3%
Q3 24
9.0%
2.9%
Q2 24
7.5%
4.7%
Q1 24
7.1%
-1.0%
Net Margin
SCVL
SCVL
VERX
VERX
Q4 25
4.9%
-3.6%
Q3 25
6.3%
2.1%
Q2 25
3.4%
-0.5%
Q1 25
5.6%
6.3%
Q4 24
6.3%
-38.0%
Q3 24
6.8%
4.2%
Q2 24
5.8%
3.2%
Q1 24
5.5%
1.7%
EPS (diluted)
SCVL
SCVL
VERX
VERX
Q4 25
$0.53
Q3 25
$0.70
Q2 25
$0.34
Q1 25
$0.53
Q4 24
$0.70
Q3 24
$0.82
Q2 24
$0.63
Q1 24
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SCVL
SCVL
VERX
VERX
Cash + ST InvestmentsLiquidity on hand
$107.7M
$314.0M
Total DebtLower is stronger
$337.5M
Stockholders' EquityBook value
$683.2M
$258.9M
Total Assets
$1.2B
$1.3B
Debt / EquityLower = less leverage
1.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SCVL
SCVL
VERX
VERX
Q4 25
$107.7M
$314.0M
Q3 25
$91.9M
$313.5M
Q2 25
$93.0M
$284.4M
Q1 25
$123.1M
$270.4M
Q4 24
$91.1M
$296.1M
Q3 24
$84.5M
$279.0M
Q2 24
$69.5M
$325.5M
Q1 24
$111.2M
$56.1M
Total Debt
SCVL
SCVL
VERX
VERX
Q4 25
$337.5M
Q3 25
$336.9M
Q2 25
$336.3M
Q1 25
$335.8M
Q4 24
$335.2M
Q3 24
$334.7M
Q2 24
$334.1M
Q1 24
$46.0M
Stockholders' Equity
SCVL
SCVL
VERX
VERX
Q4 25
$683.2M
$258.9M
Q3 25
$670.7M
$264.5M
Q2 25
$653.6M
$248.0M
Q1 25
$649.0M
$200.5M
Q4 24
$635.7M
$179.4M
Q3 24
$618.5M
$259.0M
Q2 24
$597.8M
$233.1M
Q1 24
$583.4M
$250.1M
Total Assets
SCVL
SCVL
VERX
VERX
Q4 25
$1.2B
$1.3B
Q3 25
$1.2B
$1.2B
Q2 25
$1.1B
$1.2B
Q1 25
$1.1B
$1.2B
Q4 24
$1.1B
$1.2B
Q3 24
$1.1B
$1.2B
Q2 24
$1.1B
$1.0B
Q1 24
$1.0B
$755.8M
Debt / Equity
SCVL
SCVL
VERX
VERX
Q4 25
1.30×
Q3 25
1.27×
Q2 25
1.36×
Q1 25
1.67×
Q4 24
1.87×
Q3 24
1.29×
Q2 24
1.43×
Q1 24
0.18×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SCVL
SCVL
VERX
VERX
Operating Cash FlowLast quarter
$33.6M
$42.3M
Free Cash FlowOCF − Capex
$19.7M
FCF MarginFCF / Revenue
6.6%
Capex IntensityCapex / Revenue
4.7%
Cash ConversionOCF / Net Profit
2.30×
TTM Free Cash FlowTrailing 4 quarters
$35.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SCVL
SCVL
VERX
VERX
Q4 25
$33.6M
$42.3M
Q3 25
$13.3M
$62.5M
Q2 25
$-9.6M
$46.0M
Q1 25
$44.5M
$14.8M
Q4 24
$17.3M
$41.1M
Q3 24
$23.7M
$41.4M
Q2 24
$17.1M
$57.7M
Q1 24
$53.4M
$24.6M
Free Cash Flow
SCVL
SCVL
VERX
VERX
Q4 25
$19.7M
Q3 25
$2.2M
Q2 25
$-23.0M
Q1 25
$36.2M
Q4 24
$8.3M
Q3 24
$18.2M
$-24.3M
Q2 24
$6.9M
Q1 24
$40.7M
$10.1M
FCF Margin
SCVL
SCVL
VERX
VERX
Q4 25
6.6%
Q3 25
0.7%
Q2 25
-8.3%
Q1 25
13.8%
Q4 24
2.7%
Q3 24
5.5%
-14.2%
Q2 24
2.3%
Q1 24
14.5%
6.5%
Capex Intensity
SCVL
SCVL
VERX
VERX
Q4 25
4.7%
Q3 25
3.6%
Q2 25
4.8%
Q1 25
3.2%
Q4 24
3.0%
Q3 24
1.7%
38.5%
Q2 24
3.4%
Q1 24
4.5%
9.2%
Cash Conversion
SCVL
SCVL
VERX
VERX
Q4 25
2.30×
Q3 25
0.69×
15.44×
Q2 25
-1.03×
Q1 25
3.04×
1.33×
Q4 24
0.90×
Q3 24
1.05×
5.73×
Q2 24
0.99×
11.18×
Q1 24
3.44×
9.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SCVL
SCVL

Segment breakdown not available.

VERX
VERX

Cloud Subscriptions$94.6M49%
Software Licenses$71.6M37%
Service Other$28.5M15%

Related Comparisons